Sasol Rallies 31% Before October 29 Print, but Shorts Creep Back

SSL reports on October 29, arriving on the back of a 31% rise over the past month to $18.03, making it one of the sharper recoveries among diversified chemical names this autumn.

Options traders are positioned firmly on the bullish side. The put/call ratio has dropped to 0.09, nearly two standard deviations below its 20-day average of 0.11, the lowest it has been relative to recent norms and near the floor of its 52-week range. That reflects heavy call-side positioning into the print, not a hedged or cautious market.

Short interest tells a more complicated story. The previous ORTEX preview, published October 18, described shorts retreating. That retreat has partially reversed. Short interest rose roughly 8% over the past week to around 5.4 million shares, recovering from the October 16 low of around 4.97 million. The direction has flipped from the prior article's narrative: shorts are rebuilding, not continuing to exit. Borrow costs remain low at 1.0%, and availability at 77% means the lending pool is not under pressure, so the short rebuild is happening in a market where it is cheap and easy to add positions.

The ownership picture carries one item worth flagging. Standard Bank of South Africa filed a Schedule 13D on SSL in August 2025, registering activist intent at the time. Its most recently disclosed stake has since fallen to 2.2% from 5.5%, meaning it has dropped below the 5% threshold that typically triggers a filing obligation. Under SEC rules, a holder who falls below 5% may not file again, so the current position could be lower still. The top holder remains South Africa's Public Investment Corporation, with 19% of shares. Fairtree Asset Management, a smaller South African manager, added significantly in the most recent reporting period, lifting its stake by 5.77 million shares to around 1.7% of the company.

On the analyst side, the most recent actions of substance were JP Morgan's downgrade to Neutral in June 2026 and UBS upgrading to Buy in June 2026. The mean price target on record is $20.90, implying roughly 16% above the current price, but the underlying consensus data is significantly stale and should not be treated as a current Street view. The factor score picture is mixed: earnings yield and EV/EBIT rank strongly (94th and 89th percentile respectively), pointing to a stock that screens cheaply on value. EPS surprise ranks in the 22nd percentile, meaning the company has tended to disappoint relative to forecasts.

The October 29 print will test whether the 31% monthly rally rests on improving fundamentals or whether the rebound in short interest over the past week reflects scepticism about how much of that move the earnings can justify.